Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERACYTE, INC.VCYT · Entity 2018 | Director | July 17, 2023 | July 19, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERACYTE, INC.
Report date July 17, 2023 · Filed July 19, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 33,125 |
Ending reported balance
After 2023-07-18 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2023-07-17 · Exercise / conversion · Acquired 10,000 · Balance 43,125 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023. Row 2 · 2023-07-17 · Sale · Disposed 10,000 · Balance 33,125 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023. F2: Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Row 3 · 2023-07-18 · Exercise / conversion · Acquired 10,000 · Balance 43,125 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023. Row 4 · 2023-07-18 · Sale · Disposed 10,000 · Balance 33,125 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.37 · Expires 2024-12-01 | Direct | 25,000 |
Reported balance
After 2023-07-17 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-07-17 · Exercise / conversion · Disposed 10,000 · Balance 25,000 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023. F3: The option is fully vested. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.37 · Expires 2024-12-01 | Direct | 15,000 |
Reported balance
After 2023-07-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-07-18 · Exercise / conversion · Disposed 10,000 · Balance 15,000 F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023. F3: The option is fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023.
F2: Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
F3: The option is fully vested.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CEPHEID
Report date November 04, 2016 · Filed November 07, 2016
Section 16 reporting ended · disclosed 2016-11-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2016-11-04 transaction · row 1
1 source rowRow 1 · 2016-11-04 · Disposition to issuer · Disposed 83,092 · Balance 0 F1: This number includes RSUs previously reported on Table I that at closing, were accelerated and converted into the right to receive $53 per share, without interest. F2: On September 2, 2016, the Issuer entered into an Agreement and Plan of Merger ("Merger Agreement") with Danaher Corporation, a Delaware corporation (the "Acquirer"), and Copper Merger Sub, Inc., a California corporation and a wholly-owned subsidiary of the Acquirer. Upon the closing of the transactions contemplated by the Merger Agreement on November 4, 2016 (the "Closing"), each of the Reporting Person's shares of the Issuer's Common Stock was cancelled and converted into the right to receive $53 in cash, without interest (the "Merger Consideration"). |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2016-11-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2016-11-04 · Disposition to issuer · Disposed 9,751 · Balance 0 F3: Upon the Closing, 100% of the Reporting Person's unvested RSUs were accelerated and converted into the right to receive $53.00 per share, without interest. F4: 25% of the RSUs vest on the one-year anniversary of the grant date, then 6.25% of the RSUs vest each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. |
| Performance Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2016-11-04 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-11-04 · Disposition to issuer · Disposed 75,000 · Balance 0 F5: Upon the Closing, 100% of the Reporting Person's unvested PSUs were accelerated and converted into the right to receive $53.00 per share, without interest. F6: The performance stock units will vest and be settled in shares of common stock based on the level of achievement of certain performance factors related to the company's revenue growth and operating margin over the three year performance period from January 1, 2016 to December 31, 2018. Depending on the level of performance, the number of shares of common stock delivered upon settlement can range from 0% to 125% of the target number represented above. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.47 · Expires 2017-04-29 | Direct | 0 |
Reported balance
After 2016-11-04 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2016-11-04 · Disposition to issuer · Disposed 175,000 · Balance 0 F7: Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price. F8: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.49 · Expires 2018-04-25 | Direct | 0 |
Reported balance
After 2016-11-04 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2016-11-04 · Disposition to issuer · Disposed 180,000 · Balance 0 F7: Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price. F8: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $35.72 · Expires 2019-04-24 | Direct | 0 |
Reported balance
After 2016-11-04 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2016-11-04 · Disposition to issuer · Disposed 153,750 · Balance 0 F7: Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price. F8: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.66 · Expires 2020-04-29 | Direct | 0 |
Reported balance
After 2016-11-04 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2016-11-04 · Disposition to issuer · Disposed 176,250 · Balance 0 F7: Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price. F8: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.84 · Expires 2021-04-21 | Direct | 0 |
Reported balance
After 2016-11-04 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2016-11-04 · Disposition to issuer · Disposed 176,250 · Balance 0 F7: Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price. F8: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.88 · Expires 2022-04-27 | Direct | 0 |
Reported balance
After 2016-11-04 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2016-11-04 · Disposition to issuer · Disposed 205,000 · Balance 0 F9: Upon the Closing, this option was cancelled and ceased to exist without receiving any payment therefor. F8: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $35.94 · Expires 2023-04-25 | Direct | 0 |
Reported balance
After 2016-11-04 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2016-11-04 · Disposition to issuer · Disposed 150,000 · Balance 0 F7: Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price. F8: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: This number includes RSUs previously reported on Table I that at closing, were accelerated and converted into the right to receive $53 per share, without interest.
F2: On September 2, 2016, the Issuer entered into an Agreement and Plan of Merger ("Merger Agreement") with Danaher Corporation, a Delaware corporation (the "Acquirer"), and Copper Merger Sub, Inc., a California corporation and a wholly-owned subsidiary of the Acquirer. Upon the closing of the transactions contemplated by the Merger Agreement on November 4, 2016 (the "Closing"), each of the Reporting Person's shares of the Issuer's Common Stock was cancelled and converted into the right to receive $53 in cash, without interest (the "Merger Consideration").
F3: Upon the Closing, 100% of the Reporting Person's unvested RSUs were accelerated and converted into the right to receive $53.00 per share, without interest.
F4: 25% of the RSUs vest on the one-year anniversary of the grant date, then 6.25% of the RSUs vest each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting.
F5: Upon the Closing, 100% of the Reporting Person's unvested PSUs were accelerated and converted into the right to receive $53.00 per share, without interest.
F6: The performance stock units will vest and be settled in shares of common stock based on the level of achievement of certain performance factors related to the company's revenue growth and operating margin over the three year performance period from January 1, 2016 to December 31, 2018. Depending on the level of performance, the number of shares of common stock delivered upon settlement can range from 0% to 125% of the target number represented above.
F7: Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price.
F8: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
F9: Upon the Closing, this option was cancelled and ceased to exist without receiving any payment therefor.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 18, 2023 Filed Jul 19, 2023 20:35 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0001384101-23-000132 · wk-form4_1689813334.xml · derivative · entry 6 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 10,000 shares Expires 2024-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 20:35 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 10,000 | $30.50 | $305,000.00 |
DisclosureSEC source: 0001384101-23-000132 · wk-form4_1689813334.xml · nonDerivative · entry 4 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,125 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023. Read SEC document |
| July 18, 2023 Filed Jul 19, 2023 20:35 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 10,000 | $6.37 | $63,700.00 |
DisclosureSEC source: 0001384101-23-000132 · wk-form4_1689813334.xml · nonDerivative · entry 3 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:35 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $6.37 | $0.00 |
DisclosureSEC source: 0001384101-23-000132 · wk-form4_1689813334.xml · derivative · entry 5 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 10,000 shares Expires 2024-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023. F3 · derivative.exercise_date: The option is fully vested. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:35 UTC | VERACYTE, INC. VCYT · Entity 2018 | SaleCommon Stock | 10,000 | $30.00 | $300,002.00 |
DisclosureSEC source: 0001384101-23-000132 · wk-form4_1689813334.xml · nonDerivative · entry 2 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 33,125 F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023. F2 · price: Represents weighted average sales price. Sale prices for the transactions range from $30.00 to $30.03. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:35 UTC | VERACYTE, INC. VCYT · Entity 2018 | Exercise / conversionCommon Stock | 10,000 | $6.37 | $63,700.00 |
DisclosureSEC source: 0001384101-23-000132 · wk-form4_1689813334.xml · nonDerivative · entry 1 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 28, 2023. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 17:22 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 9,674 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-23-000126 · wf-form4_168669133529895.xml · nonDerivative · entry 1 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,125 F1 · kind: Restricted stock units awarded on June 9, 2023 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 16, 2022 Filed Jun 16, 2022 20:11 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 14,731 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-22-000095 · wf-form4_165542470157099.xml · nonDerivative · entry 1 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,451 F1 · kind: Restricted stock units awarded on June 16, 2022 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 08, 2021 Filed Jun 10, 2021 16:12 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantCommon Stock | 8,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001384101-21-000110 · wf-form4_162335591682903.xml · nonDerivative · entry 1 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,720 F1 · kind: Restricted stock units awarded on June 8, 2021 vest in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the restricted stock units vest in full in the event of a change in control of the Issuer. Read SEC document |
| June 08, 2020 Filed Jun 9, 2020 16:26 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $26.30 | $0.00 |
DisclosureSEC source: 0001384101-20-000085 · wf-form4_159173439149687.xml · derivative · entry 1 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on June 8, 2021 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 12, 2019 Filed Jun 13, 2019 16:48 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $27.01 | $0.00 |
DisclosureSEC source: 0001384101-19-000080 · wf-form4_156045888197425.xml · derivative · entry 1 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-11 F1 · derivative.exercise_date: The option becomes exercisable in full on June 12, 2020 or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 07, 2018 Filed Jun 7, 2018 17:06 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.60 | $0.00 |
DisclosureSEC source: 0001384101-18-000036 · wf-form4_152840555360439.xml · derivative · entry 1 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2028-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| June 07, 2017 Filed Jun 7, 2017 17:22 UTC | VERACYTE, INC. VCYT · Entity 2018 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $7.94 | $0.00 |
DisclosureSEC source: 0001384101-17-000040 · wf-form4_149687052224401.xml · derivative · entry 1 BISHOP JOHN L · CIK 0001189846 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-06-07 F1 · derivative.exercise_date: The option becomes exercisable in full on the first anniversary of the date of the grant or immediately prior to the Company's next annual meeting of stockholders, if earlier. In addition, the option vests in full in the event of a change in control of the Company. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 19:38 UTC | CEPHEID CPHD · Entity 181259 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $35.94 | $0.00 |
DisclosureSEC source: 0001209191-16-148752 · doc4.xml · derivative · entry 10 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150,000 shares Expires 2023-04-25 F7 · shares: Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price. F8 · derivative.exercise_date: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 19:38 UTC | CEPHEID CPHD · Entity 181259 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 205,000 | $0.00 Strike: $56.88 | $0.00 |
DisclosureSEC source: 0001209191-16-148752 · doc4.xml · derivative · entry 9 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 205,000 shares Expires 2022-04-27 F9 · shares: Upon the Closing, this option was cancelled and ceased to exist without receiving any payment therefor. F8 · derivative.exercise_date: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 19:38 UTC | CEPHEID CPHD · Entity 181259 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 176,250 | $0.00 Strike: $45.84 | $0.00 |
DisclosureSEC source: 0001209191-16-148752 · doc4.xml · derivative · entry 8 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 176,250 shares Expires 2021-04-21 F7 · shares: Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price. F8 · derivative.exercise_date: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 19:38 UTC | CEPHEID CPHD · Entity 181259 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 176,250 | $0.00 Strike: $38.66 | $0.00 |
DisclosureSEC source: 0001209191-16-148752 · doc4.xml · derivative · entry 7 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 176,250 shares Expires 2020-04-29 F7 · shares: Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price. F8 · derivative.exercise_date: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 19:38 UTC | CEPHEID CPHD · Entity 181259 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 153,750 | $0.00 Strike: $35.72 | $0.00 |
DisclosureSEC source: 0001209191-16-148752 · doc4.xml · derivative · entry 6 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 153,750 shares Expires 2019-04-24 F7 · shares: Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price. F8 · derivative.exercise_date: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 19:38 UTC | CEPHEID CPHD · Entity 181259 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 180,000 | $0.00 Strike: $31.49 | $0.00 |
DisclosureSEC source: 0001209191-16-148752 · doc4.xml · derivative · entry 5 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 180,000 shares Expires 2018-04-25 F7 · shares: Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price. F8 · derivative.exercise_date: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 19:38 UTC | CEPHEID CPHD · Entity 181259 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $20.47 | $0.00 |
DisclosureSEC source: 0001209191-16-148752 · doc4.xml · derivative · entry 4 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 175,000 shares Expires 2017-04-29 F7 · shares: Upon the Closing, 100% of these options were cancelled and converted into the right to receive an amount of cash equal to the number of shares outstanding under this option multiplied by $53 minus the option exercise price. F8 · derivative.exercise_date: 25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 19:38 UTC | CEPHEID CPHD · Entity 181259 | Disposition to issuerPerformance Stock Unit · Derivative | 75,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148752 · doc4.xml · derivative · entry 3 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires not disclosed F5 · shares: Upon the Closing, 100% of the Reporting Person's unvested PSUs were accelerated and converted into the right to receive $53.00 per share, without interest. F6 · derivative.exercise_date: The performance stock units will vest and be settled in shares of common stock based on the level of achievement of certain performance factors related to the company's revenue growth and operating margin over the three year performance period from January 1, 2016 to December 31, 2018. Depending on the level of performance, the number of shares of common stock delivered upon settlement can range from 0% to 125% of the target number represented above. F6 · derivative.expiration_date: The performance stock units will vest and be settled in shares of common stock based on the level of achievement of certain performance factors related to the company's revenue growth and operating margin over the three year performance period from January 1, 2016 to December 31, 2018. Depending on the level of performance, the number of shares of common stock delivered upon settlement can range from 0% to 125% of the target number represented above. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 19:38 UTC | CEPHEID CPHD · Entity 181259 | Disposition to issuerRestricted Stock Units · Derivative | 9,751 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-148752 · doc4.xml · derivative · entry 2 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,751 shares Expires not disclosed F3 · shares: Upon the Closing, 100% of the Reporting Person's unvested RSUs were accelerated and converted into the right to receive $53.00 per share, without interest. F4 · derivative.exercise_date: 25% of the RSUs vest on the one-year anniversary of the grant date, then 6.25% of the RSUs vest each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. F4 · derivative.expiration_date: 25% of the RSUs vest on the one-year anniversary of the grant date, then 6.25% of the RSUs vest each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. Read SEC document |
| November 04, 2016 Filed Nov 7, 2016 19:38 UTC | CEPHEID CPHD · Entity 181259 | Disposition to issuerCommon Stock | 83,092 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-16-148752 · doc4.xml · nonDerivative · entry 1 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: This number includes RSUs previously reported on Table I that at closing, were accelerated and converted into the right to receive $53 per share, without interest. F2 · price: On September 2, 2016, the Issuer entered into an Agreement and Plan of Merger ("Merger Agreement") with Danaher Corporation, a Delaware corporation (the "Acquirer"), and Copper Merger Sub, Inc., a California corporation and a wholly-owned subsidiary of the Acquirer. Upon the closing of the transactions contemplated by the Merger Agreement on November 4, 2016 (the "Closing"), each of the Reporting Person's shares of the Issuer's Common Stock was cancelled and converted into the right to receive $53 in cash, without interest (the "Merger Consideration"). Read SEC document |
| October 29, 2016 Filed Oct 31, 2016 17:00 UTC | CEPHEID CPHD · Entity 181259 | Exercise / conversionRestricted Stock Units · Derivative | 1,219 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-147503 · doc4.xml · derivative · entry 4 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,438 Underlying: Common Stock · 1,219 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person. F4 · derivative.exercise_date: 25% of the RSUs vest on the one-year anniversary of the grant date, then 6.25% of the RSUs vest each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. F4 · derivative.expiration_date: 25% of the RSUs vest on the one-year anniversary of the grant date, then 6.25% of the RSUs vest each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. Read SEC document |
| October 29, 2016 Filed Oct 31, 2016 17:00 UTC | CEPHEID CPHD · Entity 181259 | Tax withholdingCommon Stock | 637 | $52.76 | $33,608.12 |
DisclosureSEC source: 0001209191-16-147503 · doc4.xml · nonDerivative · entry 3 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,009 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares for any reason other than to cover required taxes. Read SEC document |
| October 29, 2016 Filed Oct 31, 2016 17:00 UTC | CEPHEID CPHD · Entity 181259 | Exercise / conversionCommon Stock | 1,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-147503 · doc4.xml · nonDerivative · entry 2 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,646 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person. Read SEC document |
| October 27, 2016 Filed Oct 31, 2016 17:00 UTC | CEPHEID CPHD · Entity 181259 | Tax withholdingCommon Stock | 751 | $52.92 | $39,742.92 |
DisclosureSEC source: 0001209191-16-147503 · doc4.xml · nonDerivative · entry 1 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,427 F1 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares for any reason other than to cover required taxes. Read SEC document |
| October 21, 2016 Filed Oct 24, 2016 17:22 UTC | CEPHEID CPHD · Entity 181259 | Exercise / conversionRestricted Stock Units · Derivative | 1,219 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-146779 · doc4.xml · derivative · entry 3 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,313 Underlying: Common Stock · 1,219 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person. F4 · derivative.exercise_date: 25% of the RSUs vest on the one-year anniversary of the grant date, then 6.25% of the RSUs vest each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. F4 · derivative.expiration_date: 25% of the RSUs vest on the one-year anniversary of the grant date, then 6.25% of the RSUs vest each quarterly anniversary thereafter, until such time as the RSUs are 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting. Read SEC document |
| October 21, 2016 Filed Oct 24, 2016 17:22 UTC | CEPHEID CPHD · Entity 181259 | Tax withholdingCommon Stock | 637 | $52.80 | $33,633.60 |
DisclosureSEC source: 0001209191-16-146779 · doc4.xml · nonDerivative · entry 2 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,178 F2 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares for any reason other than to cover required taxes. Read SEC document |
| October 21, 2016 Filed Oct 24, 2016 17:22 UTC | CEPHEID CPHD · Entity 181259 | Exercise / conversionCommon Stock | 1,219 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-146779 · doc4.xml · nonDerivative · entry 1 BISHOP JOHN L · CIK 0001189846 · Director · Chairman of the Board and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,815 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.